Safety, Effectiveness and Tolerance of Buprenorphine-Naloxone in the Treatment of Opioid Dependence: Results from a Nationwide Non-Interventional Study in Routine Care-Reference-Cited by-同舟云学术

Safety, Effectiveness and Tolerance of Buprenorphine-Naloxone in the Treatment of Opioid Dependence: Results from a Nationwide Non-Interventional Study in Routine Care

Published:2013-01-04 Issue:03 Volume:46 Page:94-107
ISSN:0176-3679
Container-title:Pharmacopsychiatry
language:en
Short-container-title:Pharmacopsychiatry

Author:

Apelt S.¹,Scherbaum N.²,Gölz J.³,Backmund M.⁴,Soyka M.⁴

Affiliation:

1. Certum Consulting - Scientific Research, Oberbergkirchen, Germany

2. LVR-Klinikum Essen, Universität Duisburg-Essen, Suchtforschungsgruppe an der Klinik für Psychiatrie und Psychotherapie, Essen, Germany

3. Praxiszentrum Kaiserdamm, Berlin, Germany

4. Psychiatric Hospital, Ludwig Maximilian University, Munich, Germany

Publisher

Georg Thieme Verlag KG

Subject

Pharmacology (medical),Psychiatry and Mental health,General Medicine

Link

http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-0032-1330033.pdf

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessing predictors of adequate individual buprenorphine maintenance dosage for the treatment of opioid use disorder: Listening to the patient;International Journal of Drug Policy;2024-08

2. Systematic review and meta-analysis of changes in quality of life following initiation of buprenorphine for opioid use disorder;Drug and Alcohol Dependence;2022-06

3. Comparing characteristics and outcomes of different opioid agonist treatment modalities among opioid-dependent federal men correctional populations in Canada;International Journal of Drug Policy;2022-02

4. Addiction Recovery Among Opioid-Dependent Patients Treated With Injectable Subcutaneous Depot Buprenorphine: Study Protocol of a Non-randomized Prospective Observational Study (ARIDE);Frontiers in Psychiatry;2020-12-08

5. All-Cause and Cause-Specific Mortality Among People Using Extramedical Opioids;JAMA Psychiatry;2020-05-01